238 related articles for article (PubMed ID: 22626633)
1. Comparison of neuroleptic malignant syndrome induced by first- and second-generation antipsychotics.
Trollor JN; Chen X; Chitty K; Sachdev PS
Br J Psychiatry; 2012 Jul; 201(1):52-6. PubMed ID: 22626633
[TBL] [Abstract][Full Text] [Related]
2. Neuroleptic malignant syndrome and atypical antipsychotic drugs.
Ananth J; Parameswaran S; Gunatilake S; Burgoyne K; Sidhom T
J Clin Psychiatry; 2004 Apr; 65(4):464-70. PubMed ID: 15119907
[TBL] [Abstract][Full Text] [Related]
3. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
4. Neuroleptic malignant syndrome associated with atypical antipsychotic drugs.
Trollor JN; Chen X; Sachdev PS
CNS Drugs; 2009; 23(6):477-92. PubMed ID: 19480467
[TBL] [Abstract][Full Text] [Related]
5. Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis.
Belvederi Murri M; Guaglianone A; Bugliani M; Calcagno P; Respino M; Serafini G; Innamorati M; Pompili M; Amore M
Drugs R D; 2015 Mar; 15(1):45-62. PubMed ID: 25578944
[TBL] [Abstract][Full Text] [Related]
6. Mortality of neuroleptic malignant syndrome induced by typical and atypical antipsychotic drugs: a propensity-matched analysis from the Japanese Diagnosis Procedure Combination database.
Nakamura M; Yasunaga H; Miyata H; Shimada T; Horiguchi H; Matsuda S
J Clin Psychiatry; 2012 Apr; 73(4):427-30. PubMed ID: 22154901
[TBL] [Abstract][Full Text] [Related]
7. Neuroleptic malignant syndrome induced by atypical antipsychotics.
Farver DK
Expert Opin Drug Saf; 2003 Jan; 2(1):21-35. PubMed ID: 12904122
[TBL] [Abstract][Full Text] [Related]
8. Clozapine-associated neuroleptic malignant syndrome: two new cases and a review of the literature.
Karagianis JL; Phillips LC; Hogan KP; LeDrew KK
Ann Pharmacother; 1999 May; 33(5):623-30. PubMed ID: 10369628
[TBL] [Abstract][Full Text] [Related]
9. Amisulpride and neuroleptic malignant syndrome.
Tu MC; Hsiao CC
Chang Gung Med J; 2011; 34(5):536-40. PubMed ID: 22035899
[TBL] [Abstract][Full Text] [Related]
10. Olanzapine induced neuroleptic malignant syndrome--a case review.
Kogoj A; Velikonja I
Hum Psychopharmacol; 2003 Jun; 18(4):301-9. PubMed ID: 12766935
[TBL] [Abstract][Full Text] [Related]
11. [Neuroleptic malignant syndrome after treatment with olanzapine].
Emborg C
Ugeskr Laeger; 1999 Mar; 161(10):1424-5. PubMed ID: 10085753
[TBL] [Abstract][Full Text] [Related]
12. Atypical neuroleptic malignant syndrome with long-term clozapine.
Corallo CE; Ernest D
Crit Care Resusc; 2007 Dec; 9(4):338-40. PubMed ID: 18052897
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotics and Risk of Neuroleptic Malignant Syndrome: A Population-Based Cohort and Case-Crossover Study.
Lao KSJ; Zhao J; Blais JE; Lam L; Wong ICK; Besag FMC; Chang WC; Castle DJ; Chan EW
CNS Drugs; 2020 Nov; 34(11):1165-1175. PubMed ID: 33010024
[TBL] [Abstract][Full Text] [Related]
14. Clozapine Rechallenge Following Neuroleptic Malignant Syndrome: A Systematic Review.
Lally J; McCaffrey C; OʼMurchu C; Krivoy A; Guerandel A; MacCabe JH; Gaughran F
J Clin Psychopharmacol; 2019; 39(4):372-379. PubMed ID: 31205196
[TBL] [Abstract][Full Text] [Related]
15. Adverse reaction reports of neuroleptic malignant syndrome induced by atypical antipsychotic agents in the Japanese Adverse Drug Event Report (JADER) database.
Anzai T; Takahashi K; Watanabe M
Psychiatry Clin Neurosci; 2019 Jan; 73(1):27-33. PubMed ID: 30375086
[TBL] [Abstract][Full Text] [Related]
16. Reconsidering Rigidity in the Diagnosis of Neuroleptic Malignant Syndrome: A Case Report.
El Khoury R; Kassab A; Dagher R; Javelot H; El Chammay R; Richa S
J Psychiatr Pract; 2020 Jul; 26(4):320-323. PubMed ID: 32692129
[TBL] [Abstract][Full Text] [Related]
17. Clinical and pharmacologic risk factors for neuroleptic malignant syndrome and their association with death.
Tural U; Onder E
Psychiatry Clin Neurosci; 2010 Feb; 64(1):79-87. PubMed ID: 20416027
[TBL] [Abstract][Full Text] [Related]
18. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.
Musselman ME; Browning LA; Parker D; Saely S
Ann Pharmacother; 2011 Nov; 45(11):e61. PubMed ID: 21972252
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic malignant syndrome-an 11-year longitudinal case-control study.
Nielsen RE; Wallenstein Jensen SO; Nielsen J
Can J Psychiatry; 2012 Aug; 57(8):512-8. PubMed ID: 22854034
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptic malignant syndrome associated with long-term clozapine treatment: report of a case and results of a clozapine rechallenge.
Huang TL
Chang Gung Med J; 2001 Aug; 24(8):522-5. PubMed ID: 11601195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
